29 studies found for:    " October 19, 2011":" November 18, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" October 19, 2011":" November 18, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
Phase 3b Open Label Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV 1 Infected Patients
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: Stribild;   Drug: RTV;   Drug: FTC/TDF;   Drug: PI
2 Recruiting On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men
Condition: HIV Infection
Interventions: Drug: Truvada;   Drug: Placebo
3 Withdrawn Trial of Probiotics to Lower Microbial Translocation and Immune Activation in HIV-Infected Adolescents
Condition: HIV Infection
Interventions: Dietary Supplement: Probiotics;   Dietary Supplement: Placebo
4 Completed Problems With Immune Recovery in the Gut Tissue
Condition: Human Immunodeficiency Virus
Intervention: Procedure: Genital and rectal swabbing
5 Active, not recruiting Tissue Drug Levels of HIV Medications
Condition: Human Immunodeficiency Virus
Intervention: Drug: Initiation of anti-retroviral therapy
6 Completed A Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 and Rilpivirine and Dolutegravir and Rilpivirine in Healthy Adult Subjects
Condition: Infections, Human Immunodeficiency Virus and Hepatitis
Interventions: Drug: Dolutegravir;   Drug: Rlipivirine;   Drug: GSK1265744
7 Completed A Study of Doravirine (MK-1439) in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439-005)
Condition: HIV-1 Infection
Interventions: Drug: Doravirine;   Drug: Placebo
8 Completed A Study to Evaluate the Safety of the HIV-1 Vaccine MVA-B in Chronic HIV-1 Infected Patients Successfully Treated With HAART
Condition: HIV Infection
Interventions: Drug: Vaccination;   Drug: Placebo
9 Completed Pilot Study: Acceptability, Feasibility and Efficacy of Vaginal Insemination in HIV Discordant Couples (Female Positive, Male Negative) Desiring Conception in Kisumu, Kenya
Condition: HIV Discordant Couples
Intervention: Procedure: Vaginal Insemination
10 Unknown  Bioequivalence Study of Pediatric Formulations to Treat HIV Infection
Conditions: HIV;   AIDS
Interventions: Drug: Epivir®, Retrovir® and Viramune®;   Drug: Lamivudine, Zidovudine and nevirapine;   Drug: Lamivudine, zidovudine, nevirapine
11 Completed The Effect of Hyperbilirubinemia on CV Disease, Neurocog Function and Renal Function
Condition: HIV
Intervention:
12 Active, not recruiting School Support as Structural HIV Prevention for Adolescent Orphans in Kenya
Condition: HIV
Intervention: Behavioral: School Support Intervention
13 Recruiting Reducing High Risk Behavior in Treatment Court
Conditions: Substance Abuse;   HIV
Interventions: Behavioral: Computer-facilitated HIV intervention;   Behavioral: Attention Control
14 Completed Atazanavir/Ritonavir and Zinc Pharmacokinetic Study
Condition: HIV Infection
Interventions: Drug: 1 Solvazinc tablet, day 2 to day 15;   Drug: 1 Solvazinc tablet, day 15 to day 28
15 Terminated Investigation of The Effect of Cenicriviroc (CVC) Plus FTC/TDF on Cardiovascular Disease Risk Factors
Condition: HIV Infection
Intervention:
16 Completed Intranasal Modified Vacc-4x Gag Peptides With Endocine as Adjuvant
Condition: HIV Infection
Interventions: Biological: Vacc-4x low dose;   Biological: Vacc-4x medium dose;   Biological: Vacc-4x high dose;   Biological: Zero dose
17 Completed Efficacy of Raltegravir in a Large Urban HIV Clinical Population in Milan
Condition: HIV Infections
Intervention:
18 Completed Methadone-Dolutegravir (DTG - GSK1349572) Drug Interaction Study.
Condition: Infections, Human Immunodeficiency Virus and Hepatitis
Interventions: Drug: Dolutegravir;   Drug: Methadone
19 Unknown  Comorbidity and Aging With HIV
Conditions: HIV-1-infection;   Comorbidity;   Ageing
Intervention:
20 Completed Safety and Efficacy Study of BMS-790052 Plus Peg-Interferon Alfa 2a and Ribavirin in Untreated Hepatitis C Patients Coinfected With HIV Virus
Condition: Hepatitis C, Genotype 1
Interventions: Drug: BMS-790052 (Daclatasvir);   Drug: Ribavirin;   Drug: Peg-Interferon alfa 2a

   Previous Page Studies Shown (1-20) Next Page (21-29) Show next page of results    Last Page
Indicates status has not been verified in more than two years